# OnCo record masofaniten (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/masofaniten/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "masofaniten" ;
  schema:name "Masofaniten"@en ;
  schema:description "A drug designed to block the part of the androgen receptor that resistant variants keep; its phase 2 was stopped for futility and development ended."@en ;
  schema:url <https://onco.cc/drugs/masofaniten/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://www.onclive.com/view/essa-discontinues-phase-2-study-of-masofaniten-plus-enzalutamide-in-mcrpc> ;
  onco:status "withdrawn" ;
  onco:tag "failed-so-far" ;
  onco:modality "Small-molecule AR N-terminal domain inhibitor" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/essa-pharma/> ;
  onco:terms <https://onco.cc/terms/ar-v7/> ;
  onco:trials <https://onco.cc/trials/nct06312670/> .